Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 89

1.

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies.

Dan TD, Eldredge-Hindy HB, Hoffman-Censits J, Lin J, Kelly WK, Gomella LG, Lallas CD, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB.

Am J Clin Oncol. 2015 Feb 25. [Epub ahead of print]

PMID:
25723740
2.

Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.

de Leeuw R, Berman-Booty LD, Schiewer MJ, Ciment SJ, Den RB, Dicker AP, Kelly WK, Trabulsi EJ, Lallas CD, Gomella LG, Knudsen KE.

Clin Cancer Res. 2015 Feb 15;21(4):795-807. doi: 10.1158/1078-0432.CCR-14-1358.

PMID:
25691773
3.

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

Den RB, Yousefi K, Trabulsi EJ, Abdollah F, Choeurng V, Feng FY, Dicker AP, Lallas CD, Gomella LG, Davicioni E, Karnes RJ.

J Clin Oncol. 2015 Mar 10;33(8):944-51. doi: 10.1200/JCO.2014.59.0026. Epub 2015 Feb 9.

PMID:
25667284
4.

Is robotic arm stereotactic body radiation therapy 'virtual high-dose rate brachytherapy' effective for prostate cancer? An analysis of comparative effectiveness using published data.

Zaorsky NG, Hurwitz MD, Dicker AP, Showalter TN, Den RB.

Expert Rev Med Devices. 2014 Dec 25:1-11. [Epub ahead of print]

PMID:
25540018
5.

RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.

Prensner JR, Zhao S, Erho N, Schipper M, Iyer MK, Dhanasekaran SM, Magi-Galluzzi C, Mehra R, Sahu A, Siddiqui J, Davicioni E, Den RB, Dicker AP, Karnes RJ, Wei JT, Klein EA, Jenkins RB, Chinnaiyan AM, Feng FY.

Lancet Oncol. 2014 Dec;15(13):1469-80. doi: 10.1016/S1470-2045(14)71113-1. Epub 2014 Nov 17.

PMID:
25456366
6.

Effect of docetaxel on safety and efficacy of radium-223.

Den RB, Kelly WK.

Lancet Oncol. 2014 Nov;15(12):1292-3. doi: 10.1016/S1470-2045(14)71026-5. Epub 2014 Oct 17. No abstract available.

PMID:
25439686
7.

Predictors of positive surgical margins after radical prostatectomy at a single institution: preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location.

Lallas CD, Fashola Y, Den RB, Gelpi-Hammerschmidt F, Calvaresi AE, McCue P, Birbe R, Gomella LG, Trabulsi EJ.

Can J Urol. 2014 Oct;21(5):7479-86.

PMID:
25347375
8.

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer.

Eldredge-Hindy HB, Eastwick G, Anne PR, Rosenblum NG, Schilder RJ, Chalian R, Zibelli AM, Kim CH, Den R.

J Contemp Brachytherapy. 2014 Oct;6(3):262-70. doi: 10.5114/jcb.2014.45031. Epub 2014 Sep 5.

9.

Uncertainties encountered in implementation of adaptive planning with in vivo dosimeters.

Studenski MT, Gardner SJ, Den RB.

Radiol Phys Technol. 2015 Jan;8(1):81-7. doi: 10.1007/s12194-014-0291-0. Epub 2014 Sep 19.

PMID:
25236778
10.

Timing of adjunctive therapy in the treatment of depression: a chart review.

Tarumi R, Suzuki T, Tani H, Den R, Sawada N, Sakurai H, Tsutsumi-Ozawa C, Ohtani A, Mimura M, Uchida H.

Pharmacopsychiatry. 2014 Nov;47(7):259-62. doi: 10.1055/s-0034-1387784. Epub 2014 Sep 2.

PMID:
25181576
11.

The retinoblastoma tumor suppressor modulates DNA repair and radioresponsiveness.

Thangavel C, Boopathi E, Ciment S, Liu Y, O' Neill R, Sharma A, McMahon SB, Mellert H, Addya S, Ertel A, Birbe R, Fortina P, Dicker AP, Knudsen KE, Den RB.

Clin Cancer Res. 2014 Nov 1;20(21):5468-82. doi: 10.1158/1078-0432.CCR-14-0326. Epub 2014 Aug 27.

PMID:
25165096
12.

The lag time in initiating clinical testing of new drugs in combination with radiation therapy, a significant barrier to progress?

Blumenfeld P, Pfeffer RM, Symon Z, Den RB, Dicker AP, Raben D, Lawrence YR.

Br J Cancer. 2014 Sep 23;111(7):1305-9. doi: 10.1038/bjc.2014.448. Epub 2014 Aug 12.

PMID:
25117813
13.

Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy.

Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP.

Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1038-46. doi: 10.1016/j.ijrobp.2014.04.052. Epub 2014 Jul 8.

14.

Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma.

Yamoah K, Eldredge-Hindy HB, Zaorsky NG, Palmer JD, Doyle LA, Sendecki JA, Hesney AA, Harper L, Repka M, Showalter TN, Hurwitz MD, Dicker AP, Den RB.

Brachytherapy. 2014 Sep-Oct;13(5):456-64. doi: 10.1016/j.brachy.2014.04.003. Epub 2014 Jun 18.

PMID:
24953945
15.

Practical guide to the use of radium 223 dichloride.

Den RB, Doyle LA, Knudsen KE.

Can J Urol. 2014 Apr;21(2 Supp 1):70-6. Review.

16.

A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.

Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB.

Future Oncol. 2014 Feb;10(3):457-74. doi: 10.2217/fon.13.196. Review.

PMID:
24559451
17.

AR function in promoting metastatic prostate cancer.

Augello MA, Den RB, Knudsen KE.

Cancer Metastasis Rev. 2014 Sep;33(2-3):399-411. doi: 10.1007/s10555-013-9471-3.

PMID:
24425228
18.

Phase I trials involving radiation therapy, quantifying the risks.

Lawrence YR, Glass C, Symon Z, Dicker AP, Den RB.

J Med Imaging Radiat Oncol. 2013 Dec;57(6):719-24. doi: 10.1111/1754-9485.12082. Epub 2013 May 31.

PMID:
24283562
19.

High dose rate brachytherapy boost for prostate cancer: a systematic review.

Zaorsky NG, Doyle LA, Yamoah K, Andrel JA, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB.

Cancer Treat Rev. 2014 Apr;40(3):414-25. doi: 10.1016/j.ctrv.2013.10.006. Epub 2013 Oct 26. Review.

PMID:
24231548
20.

Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer.

Zaorsky NG, Den RB, Doyle LA, Dicker AP, Hurwitz MD.

Expert Rev Med Devices. 2013 Nov;10(6):751-63. doi: 10.1586/17434440.2013.841347. Review.

PMID:
24195459
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk